Exploratory study for dry eye patient satisfaction with treatment
- Conditions
- Dry eye
- Registration Number
- JPRN-UMIN000030038
- Lead Sponsor
- Santen Pharmaceutical Co., Ltd.
- Brief Summary
Inclusion for Analysis: 100 cases [20 males,80 females, Age:70.7 plus or minus 11.2, Elapsed time since diagnosis of dry eye: 62.7 plus or minus 35.7 months] Treatment satisfaction: Very satisfied 10.0%, satisfied 43.0%, normal 44.0%, dissatisfied 3.0%. Factor analysis of satisfaction [the most important reason for satisfaction]: moisture feeling 29.0%, dryness improvement 19.0%, foreign body sensation improvement 15.0%. Relationship between patient background and ophthalmic findings / symptoms: No clear correlation was found. DEQS score: 13.6 plus or minus 13.3, BUT: 3.9 plus or minus 2.3 sec, corneal and conjunctival staining score: 2.2 plus or minus 1.9, LWE with 30.8%, conjunctival relaxation with 29.3%, SLK with 15.7%, Meibomian Gland abnormalities 80.8%.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
Having advanced ocular disorder due to ocular pemphigus or Stevens Johnson syndrome Using a punctal plug and performing a punctal closure procedure Diquafosol sodium ophthalmic solution and sodium hyaluronate ophthalmic solution are used in combination. Treated with Rebamipide suspension eye drop Subject with hypersensitivity to fluorescein The investigator judges that the subject is ineligible as the study subject.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment satisfaction Factor analysis of satisfaction Relationship between patient background and ophthalmic findings / symptoms
- Secondary Outcome Measures
Name Time Method